Mark Burgess Keatley

Mr. Mark B. Keatley is an Independent Director at Karo Healthcare AB, a Member at The Chartered Institute of Management Accountants and a Principal at Ridgemark Advisors.
He is on the Board of Directors at Recipharm AB, Karo Healthcare AB and Medichem SA. Mr. Keatley was previously employed as a Chief Financial Officer by STADA Arzneimittel AG, a Member-Supervisory Board by Play Topco SA, a Partner by Albrecht Prock & Partners AG, a Chief Financial Officer by Actavis Group hf, an Independent Director by King Global Ventures, Inc., a Chief Financial Officer by Famar SA, a Chief Financial Officer by Ardana Bioscience Ltd., a Chief Financial Officer by Ashanti Goldfields Co. Ltd., a Division Manager by International Finance Corp., and a Chief Financial Officer by Actavis SARL. He received his graduate degree from the University of Cambridge and an MBA from Stanford Graduate School of Business.